Selected research
Market Analysis & Forecast
Global Epigenetics Services Market Analysis and Forecast 2026-2032
Market perspective
The global Epigenetics Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Epigenetics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Epigenetics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Epigenetics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Epigenetics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Epigenetics Services include Bio-Rad, lllumina, QIAGEN, Thermo Fisher, Active Motif, Diagenode, Agilent, Merck Millipore and Abcam, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Epigenetics Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Epigenetics Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Epigenetics Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Epigenetics Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Epigenetics Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Epigenetics Services revenue, projected growth trends, production technology, application and end-user industry.
Epigenetics Services Segment by Company
Bio-Rad
lllumina
QIAGEN
Thermo Fisher
Active Motif
Diagenode
Agilent
Merck Millipore
Abcam
New England Biolabs+
PerkinEImer
Zymo Research
Epigenetics Services Segment by Type
DNA Methylation
Histone Modification
Others
Epigenetics Services Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organization (CRO)
Epigenetics Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epigenetics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Epigenetics Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Epigenetics Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenetics Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Methylation
- Histone Modification
- Others
Applications
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organization (CRO)
Companies covered
- Bio-Rad
- lllumina
- QIAGEN
- Thermo Fisher
- Active Motif
- Diagenode
- Agilent
- Merck Millipore
- Abcam
- New England Biolabs+
- PerkinEImer
- Zymo Research
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Epigenetics Services Market by Type
- 1.2.1 Global Epigenetics Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 DNA Methylation
- 1.2.3 Histone Modification
- 1.2.4 Others
- 1.3 Epigenetics Services Market by Application
- 1.3.1 Global Epigenetics Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Academic and Research Institutes
- 1.3.3 Pharmaceutical and Biotechnology Companies
- 1.3.4 Contract Research Organization (CRO)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Epigenetics Services Market Dynamics
- 2.1 Epigenetics Services Industry Trends
- 2.2 Epigenetics Services Industry Drivers
- 2.3 Epigenetics Services Industry Opportunities and Challenges
- 2.4 Epigenetics Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Epigenetics Services Market Perspective (2021-2032)
- 3.2 Global Epigenetics Services Growth Trends by Region
- 3.2.1 Global Epigenetics Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Epigenetics Services Market Size by Region (2021-2026)
- 3.2.3 Global Epigenetics Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Epigenetics Services Revenue by Players
- 4.1.1 Global Epigenetics Services Revenue by Players (2021-2026)
- 4.1.2 Global Epigenetics Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Epigenetics Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Epigenetics Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Epigenetics Services Key Players Headquarters & Area Served
- 4.4 Global Epigenetics Services Players, Product Type & Application
- 4.5 Global Epigenetics Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Epigenetics Services Market CR5 and HHI
- 4.6.3 2025 Epigenetics Services Tier 1, Tier 2, and Tier 3
5 Epigenetics Services Market Size by Type
- 5.1 Global Epigenetics Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Epigenetics Services Revenue by Type (2021-2032)
- 5.3 Global Epigenetics Services Revenue Market Share by Type (2021-2032)
6 Epigenetics Services Market Size by Application
- 6.1 Global Epigenetics Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Epigenetics Services Revenue by Application (2021-2032)
- 6.3 Global Epigenetics Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Bio-Rad
- 7.1.1 Bio-Rad Company Information
- 7.1.2 Bio-Rad Business Overview
- 7.1.3 Bio-Rad Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Bio-Rad Epigenetics Services Product Portfolio
- 7.1.5 Bio-Rad Recent Developments
- 7.2 lllumina
- 7.2.1 lllumina Company Information
- 7.2.2 lllumina Business Overview
- 7.2.3 lllumina Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.2.4 lllumina Epigenetics Services Product Portfolio
- 7.2.5 lllumina Recent Developments
- 7.3 QIAGEN
- 7.3.1 QIAGEN Company Information
- 7.3.2 QIAGEN Business Overview
- 7.3.3 QIAGEN Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.3.4 QIAGEN Epigenetics Services Product Portfolio
- 7.3.5 QIAGEN Recent Developments
- 7.4 Thermo Fisher
- 7.4.1 Thermo Fisher Company Information
- 7.4.2 Thermo Fisher Business Overview
- 7.4.3 Thermo Fisher Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.4.4 Thermo Fisher Epigenetics Services Product Portfolio
- 7.4.5 Thermo Fisher Recent Developments
- 7.5 Active Motif
- 7.5.1 Active Motif Company Information
- 7.5.2 Active Motif Business Overview
- 7.5.3 Active Motif Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Active Motif Epigenetics Services Product Portfolio
- 7.5.5 Active Motif Recent Developments
- 7.6 Diagenode
- 7.6.1 Diagenode Company Information
- 7.6.2 Diagenode Business Overview
- 7.6.3 Diagenode Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Diagenode Epigenetics Services Product Portfolio
- 7.6.5 Diagenode Recent Developments
- 7.7 Agilent
- 7.7.1 Agilent Company Information
- 7.7.2 Agilent Business Overview
- 7.7.3 Agilent Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Agilent Epigenetics Services Product Portfolio
- 7.7.5 Agilent Recent Developments
- 7.8 Merck Millipore
- 7.8.1 Merck Millipore Company Information
- 7.8.2 Merck Millipore Business Overview
- 7.8.3 Merck Millipore Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Merck Millipore Epigenetics Services Product Portfolio
- 7.8.5 Merck Millipore Recent Developments
- 7.9 Abcam
- 7.9.1 Abcam Company Information
- 7.9.2 Abcam Business Overview
- 7.9.3 Abcam Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Abcam Epigenetics Services Product Portfolio
- 7.9.5 Abcam Recent Developments
- 7.10 New England Biolabs+
- 7.10.1 New England Biolabs+ Company Information
- 7.10.2 New England Biolabs+ Business Overview
- 7.10.3 New England Biolabs+ Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.10.4 New England Biolabs+ Epigenetics Services Product Portfolio
- 7.10.5 New England Biolabs+ Recent Developments
- 7.11 PerkinEImer
- 7.11.1 PerkinEImer Company Information
- 7.11.2 PerkinEImer Business Overview
- 7.11.3 PerkinEImer Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.11.4 PerkinEImer Epigenetics Services Product Portfolio
- 7.11.5 PerkinEImer Recent Developments
- 7.12 Zymo Research
- 7.12.1 Zymo Research Company Information
- 7.12.2 Zymo Research Business Overview
- 7.12.3 Zymo Research Epigenetics Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Zymo Research Epigenetics Services Product Portfolio
- 7.12.5 Zymo Research Recent Developments
8 North America
- 8.1 North America Epigenetics Services Revenue (2021-2032)
- 8.2 North America Epigenetics Services Revenue by Type (2021-2032)
- 8.2.1 North America Epigenetics Services Revenue by Type (2021-2026)
- 8.2.2 North America Epigenetics Services Revenue by Type (2027-2032)
- 8.3 North America Epigenetics Services Revenue Share by Type (2021-2032)
- 8.4 North America Epigenetics Services Revenue by Application (2021-2032)
- 8.4.1 North America Epigenetics Services Revenue by Application (2021-2026)
- 8.4.2 North America Epigenetics Services Revenue by Application (2027-2032)
- 8.5 North America Epigenetics Services Revenue Share by Application (2021-2032)
- 8.6 North America Epigenetics Services Revenue by Country
- 8.6.1 North America Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Epigenetics Services Revenue by Country (2021-2026)
- 8.6.3 North America Epigenetics Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Epigenetics Services Revenue (2021-2032)
- 9.2 Europe Epigenetics Services Revenue by Type (2021-2032)
- 9.2.1 Europe Epigenetics Services Revenue by Type (2021-2026)
- 9.2.2 Europe Epigenetics Services Revenue by Type (2027-2032)
- 9.3 Europe Epigenetics Services Revenue Share by Type (2021-2032)
- 9.4 Europe Epigenetics Services Revenue by Application (2021-2032)
- 9.4.1 Europe Epigenetics Services Revenue by Application (2021-2026)
- 9.4.2 Europe Epigenetics Services Revenue by Application (2027-2032)
- 9.5 Europe Epigenetics Services Revenue Share by Application (2021-2032)
- 9.6 Europe Epigenetics Services Revenue by Country
- 9.6.1 Europe Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Epigenetics Services Revenue by Country (2021-2026)
- 9.6.3 Europe Epigenetics Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Epigenetics Services Revenue (2021-2032)
- 10.2 China Epigenetics Services Revenue by Type (2021-2032)
- 10.2.1 China Epigenetics Services Revenue by Type (2021-2026)
- 10.2.2 China Epigenetics Services Revenue by Type (2027-2032)
- 10.3 China Epigenetics Services Revenue Share by Type (2021-2032)
- 10.4 China Epigenetics Services Revenue by Application (2021-2032)
- 10.4.1 China Epigenetics Services Revenue by Application (2021-2026)
- 10.4.2 China Epigenetics Services Revenue by Application (2027-2032)
- 10.5 China Epigenetics Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Epigenetics Services Revenue (2021-2032)
- 11.2 Asia Epigenetics Services Revenue by Type (2021-2032)
- 11.2.1 Asia Epigenetics Services Revenue by Type (2021-2026)
- 11.2.2 Asia Epigenetics Services Revenue by Type (2027-2032)
- 11.3 Asia Epigenetics Services Revenue Share by Type (2021-2032)
- 11.4 Asia Epigenetics Services Revenue by Application (2021-2032)
- 11.4.1 Asia Epigenetics Services Revenue by Application (2021-2026)
- 11.4.2 Asia Epigenetics Services Revenue by Application (2027-2032)
- 11.5 Asia Epigenetics Services Revenue Share by Application (2021-2032)
- 11.6 Asia Epigenetics Services Revenue by Country
- 11.6.1 Asia Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Epigenetics Services Revenue by Country (2021-2026)
- 11.6.3 Asia Epigenetics Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Epigenetics Services Revenue (2021-2032)
- 12.2 SAMEA Epigenetics Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Epigenetics Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Epigenetics Services Revenue by Type (2027-2032)
- 12.3 SAMEA Epigenetics Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Epigenetics Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Epigenetics Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Epigenetics Services Revenue by Application (2027-2032)
- 12.5 SAMEA Epigenetics Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Epigenetics Services Revenue by Country
- 12.6.1 SAMEA Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Epigenetics Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Epigenetics Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst